BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kayser BD, Prifti E, Lhomme M, Belda E, Dao MC, Aron-Wisnewsky J, Kontush A, Zucker JD, Rizkalla SW, Dugail I, Clément K; MICRO-Obes Consortium. Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism. Metabolomics 2019;15:140. [PMID: 31605240 DOI: 10.1007/s11306-019-1596-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Prasain JK, Barnes S. Cranberry polyphenols‐gut microbiota interactions and potential health benefits: An updated review. Food Frontiers 2020;1:459-64. [DOI: 10.1002/fft2.56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Muñoz-Prieto A, Rubić I, Horvatić A, Rafaj RB, Cerón JJ, Tvarijonaviciute A, Mrljak V. Evaluation of Changes in Metabolites of Saliva in Canine Obesity Using a Targeted Metabolomic Approach. Animals (Basel) 2021;11:2501. [PMID: 34573467 DOI: 10.3390/ani11092501] [Reference Citation Analysis]
3 Chen W, Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites 2021;11:869. [PMID: 34940628 DOI: 10.3390/metabo11120869] [Reference Citation Analysis]
4 Kim YJ, Womble JT, Gunsch CK, Ingram JL. The Gut/Lung Microbiome Axis in Obesity, Asthma, and Bariatric Surgery: A Literature Review. Obesity (Silver Spring) 2021;29:636-44. [PMID: 33759390 DOI: 10.1002/oby.23107] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? Gastroenterology 2020;158:1881-98. [PMID: 32044317 DOI: 10.1053/j.gastro.2020.01.049] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
6 Bliesner A, Eccles-smith J, Bates C, Hayes O, Ho JY, Martins C, Truby H, Nitert MD. Impact of Food-Based Weight Loss Interventions on Gut Microbiome in Individuals with Obesity: A Systematic Review. Nutrients 2022;14:1953. [DOI: 10.3390/nu14091953] [Reference Citation Analysis]
7 Cao R, Fang Z, Li S, Xu M, Zhang J, Han D, Hu W, Yan L, Wang Y, Fan L, Cao F. Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus. Front Physiol 2020;11:1104. [PMID: 33041846 DOI: 10.3389/fphys.2020.01104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Garcia-Beltran C, Malpique R, Carbonetto B, González-Torres P, Henares D, Brotons P, Muñoz-Almagro C, López-Bermejo A, de Zegher F, Ibáñez L. Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments. Pediatr Obes 2021;16:e12734. [PMID: 32989872 DOI: 10.1111/ijpo.12734] [Reference Citation Analysis]